Company News
Sudarshan Pharma Med Therapy 9.5% Acquisition Update
Sudarshan Pharma discloses ongoing due diligence for acquiring 9.5% stake in Med Therapy Biotechnology Inc., USA.
Promoters Hemal Mehta and Sachin Mehta also pursuing individual 1.5% stakes each in Me
